Original research: Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency.

Read full text Summarise with VIRAT
Authors: Christina Schrader, Malin Fromme, Paul Ellis, Audrey Payancé, Mattias Mandorfer, Jan N Stolk, Bart van Hoek, Katrine Holtz Thorhauge, Mònica Pons, Marc Miravitlles, Guido Stirnimann, Soňa Fraňková
+23 more Jan Šperl, Andreas Emanuel Kremer, Katharina Remih, E. Weber, Lorenz Balcar, Annelot D. Sark, Benedikt Schaefer, Joanna Chorostowska‐Wynimko, Elmar Stephan Aigner, Sophie Gensluckner, Heike Bantel, Jef Verbeek, Zoe Mariñó, Rohit Loomba, Heinz Zoller, Michael Trauner, Joan Genescà, Virginia Clark, Aleksander Ahm Krag, Noel Gerard McElvaney, William J. Griffiths, Alice M. Turner, Pavel Strnad
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background And Aims Severe (Pi*ZZ) and heterozygous (Pi*MZ) alpha-1 antitrypsin deficiency (AATD) confer increased liver- and lung-related mortality, but the phenotype is highly variable. We aimed to evaluate the impact of obesity and diabetes mellitus on individuals with/without AATD. Approach And Results Cohort 1 prospectively recruited 1678 Pi*ZZ adults from an international initiative with a systematic liver assessment. 983 participants had a longitudinal follow-up. The data were compared to 16,768 Pi*MZ and 415,208 non-AATD individuals from the United Kingdom Biobank (cohort 2). Findings were ascertained by multivariable adjustment and propensity score matching. At baseline, diabetes was present in 52 (3%), overweight (BMI 25.0-29.9 kg/m2) in 540 (52%) and obesity (BMI≥30 kg/m2) in 266 (32%) Pi*ZZ adults. Pi*ZZ individuals with diabetes showed higher transaminases and surrogates of advanced liver fibrosis (APRI≥1.0, LSM≥15 kPa) were four to six times more common (adjusted Odds Ratio (aOR) 5.7/4.3, p

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Pancreatitis Pathology and Treatment Protease and Inhibitor Mechanisms

Publication details

Journal / source
Open Access CRIS of the University of Bern
Publication date
1 August 2026
Language
EN